The Justice Department's Anti Trust Division is investigating Regal Entertainment Group (RGC) and AMC Entertaiment Holding (AMC). The two national movie theater chains are under scrutiny for what has been described as 'potentially anti competitive conduct'. The Justice Department is looking into the Movie chains' use of 'clearances.' The industry practice allows theaters to make deals with studios that secure exclusive rights to certain movie titles. The tactic can be used to crush smaller, competing theaters. Both Regal Entertainment Group and AMC Entertainment Holding say they do not feel they have violated antitrust laws and are co operating with government authorities. Independent theaters are hit hardest by the use of clearance deals which effectively bar them from screening new releases until much later dates. Large theater chains can refuse to play a studio movie in certain areas unless they have exclusive rights to do so. Much of the time this means that new, blockbuster releases can only be seen in chain locations. AMC, Regal Entertainment Group and Cinemark Holdings combined own over 40 percent of U.S. movie screens, giving them hard hitting negotiating power with Hollywood studios. The theater giants defend themselves by saying they only seek "clearance" for select titles and the practice is mostly to get an edge over each other rather than to crush small movie theaters.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.